Opinion &amp; analysis

Farxiga Data Change Heart Failure Treatment Outlook

AstraZeneca’s Farxiga (dapagliflozin) appears set to become new standard or care in the treatment of hear failure based on results of the DAPA-HF Phase III trial present at the European Society of Cardiology Congress on 1 September. Scrip looks at Farxiga and its nearest competitors.

August 2, 2019

How To Pay For The New Wave Of Gene Therapies

Paul Goudreau, executive director & head of Phase IV Solutions at the CRO Covance, recently told Scrip, “an ongoing and wide-ranging discussion is needed about assessment, payment and reimbursement of innovative products, as well as the evidence that supports them.”

August 2, 2019

Schakowsky’s Loaded Cosmetics Bill Described as ‘Floor, Not a Ceiling’ for States to Build On

The Safe Cosmetics and Personal Care Products Act reintroduced to the US House of Representatives calls for greater duties and resource demands on companies and the FDA than the proposed Personal Care Act in the Senate and allows room for states to impose more stringent regulations.

Sanofi’s New CEO Paul Hudson Poised To Write The Next Chapter

Less than one month into his new job, Sanofi CEO Paul Hudson shared his perspective on how he plans to build on Sanofi’s strengths and deliver needed changes. Scrip shares details about Sanofi’s leadership history and Hudson’s early priorities at the helm.

Eight Talking Points from ESMO

At the 2019 congress in Barcelona from 27 September to 1 October, the European Society for Medical Oncology (ESMO) proved once again it is a match for ASCO. Scrip shares the main points of the event including Seattle Genetics victory for mid-caps.

86% Rise In GMDN Usage Heralds New Era Of Postmarket Data Analytics

The Global Medical Device Nomenclature is emblematic of the global trend toward building high-quality data sets in the public arena to derive better information about how medical devices perform. Medtech Insight covers that the new chair of the agency saying how the GMDN usage is poised to explode.

MorphoSys: A European Champion Crossing The Biopharma Rubicon

MorphoSys, out of Munich, is one of a handful of mature European biotech companies appearing ready for greatness. In Vivo spoke with the CEO about the firm’s next generation antibody platform and why US expansion is crucial to its future.

EU Post-Market Clinical Follow Up: What Manufacturers Need To Know

The post-market clinical follow-up requirements for device and diagnostics companies based on the new medtech regulations are complex. They contain vague terms that need clarification for companies to understand how to comply. Expert and consultant Sarah Sorrel provides her interpretation in this interview with Medtech Insight.

August 2, 2019

Pharma Intelligence Report Store Article: Collection Cybersecurity

$300.00

Preventing cyberattacks on medical technology occupies the waking thoughts of device software manufacturers, but the global ransomware episode in mid-May shows that companies must also be alive to threat posed to their provider customers.

May 19, 2017

Pharma Intelligence Report Store Article Collection Digital Policy & Regulation Report 2

$300.00

Funding is taking a long time to come through for the UK NHS’s digital health care transformation, but as the national provider’s head of technology strategy, Dr Paul Rice says, “We can’t afford to remain non-digital.”

July 21, 2017

Telehealth, Wearables and Apps – Report 3

$300.00

> Reckitt Reaps ROI Reward In Geo-Targeted Symptoms App Promoting Mucinex, Delsym
> Biogen CMO Notes iPhone’s Potential For Early Detection of Alzheimer’s
> Interview: Philips Plugs Into Patient Connectivity

December 1, 2017

Pharma Intelligence Report Store Article Collection Digital Policy & Regulation Report 1

$400.00

The digital medtech sector is growing fast. As new companies enter the space, they are going to face oversight from a slew of government agencies and statutes.

March 31, 2017

Telehealth, Wearables and Apps – Report 1

$400.00

> Engaging Patients and Navigating Laws: What To Consider When Developing Health Apps
> Telehealth Reforms Praised At Senate Hearing
> Philips’ Survey Highlights Gaps In Perceptions Of Health Care
> Game On For Akili’s Cognitive Control Tech

December 1, 2017

Telehealth, Wearables and Apps – Report 2

$400.00

> Behind The Scenes Of Digital Health: Medtech Players And Partners
> Philips To Create More Context, Connectedness And Continuity And Shift Sick Care To Health Care
> New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector
> Siemens Healthineers To Launch Digital ‘One-Stop-Shop’

December 1, 2017